Covilife-24 is a product that is available by prescription and consists of 24 mg of Ivermectin USP in each uncoated tablet. Ivermectin is a medicine used against parasites, specifically those that are susceptible to it. The version of Covilife-24 that is shown is branded by Kachhela Medex Pvt. Ltd. and is packed in a pack containing 10 × 10 tablets.
Each Covilife-24 tablet which is uncoated contains 24 mg of Ivermectin USP together with the excipients used in the formulation.
Oral ivermectin is already used in medicine for some parasitic infections, and the current prescribing information for use in the United States lists intestinal strongyloidiasis due to Strongyloides stercoralis and onchocerciasis due to Onchocerca volvulus as among the conditions for which oral ivermectin is approved.
Ivermectin combats susceptible parasites by disrupting the nerve and muscle functions which are essential for their survival.
The choice of the correct ivermectin treatment will depend on a number of factors, such as the particular parasite involved, the patient's body weight, their medical history, the other medicines they are taking, and any other clinical situations.
Covilife-24 is not appropriate in all cases of parasitic infection. The fact that each tablet contains 24 mg of ivermectin does not mean that one tablet is the right dose for every patient or condition.
The fact that ivermectin has approved prescription uses in the United States does not mean that the Covilife-24 brand or its 24 mg tablet strength has been given U.S. approval.
You should use Covilife-24 as instructed by a healthcare professional since the packaging indicates that a physician should prescribe the dosage.
The dosage of ivermectin will depend on the particular infection and on the patient's body weight; you should not base your choice of treatment schedule just on the 24 mg strength listed on the package.
You should not raise the dose, go through a full course of treatment, or use Covilife-24 for any other suspected parasitic infection without first obtaining appropriate professional advice.
Tell your healthcare professional about any medical conditions you have, allergies, prescription medicines, non-prescription products, and supplements that you are currently using before you take Covilife-24.
Before taking ivermectin, you should discuss your pregnancy, breastfeeding, any liver-related conditions, and other relevant medical situations with a healthcare professional.
People can have unwanted effects when using ivermectin. If an effect is serious, lasts for a long time, is unusual or alarming, then it is advisable to obtain suitable medical help.
It is important to properly assess a suspected parasitic infection since different parasites may call for different kinds of medicine or treatment methods.
Covilife-24 should be used only when it is appropriate to administer ivermectin for the parasitic infection in question.
The fact that symptoms resemble a past parasitic infection does not mean that the condition is the same. One should not use a prescription written by another person or carry out a treatment programme that was meant for someone else.
Do not use veterinary ivermectin products in place of medicines that are formulated for human use.
The packaging of Covilife-24 tells you to store the medicine in a cool, dry and dark place and to keep the tablets in their original packaging and out of the reach of children.
Each Covilife-24 tablet which is uncoated contains 24 mg of Ivermectin USP and the product shown is branded by Kachhela Medex Pvt. Ltd. and is available in a pack of 10 × 10 tablets.
The information given on this page is only for general purposes concerning the product and must not be used in place of a diagnosis, a prescription, professional medical advice, treatment, monitoring, or the official details supplied with the medicine. The approved uses, available strengths, dosage schedules, and regulatory requirements may vary from country to country. You should follow the instructions of a properly qualified healthcare professional.